About iSchema View
RapidAI is a leading clinical AI platform company that delivers deep clinical decision support across multiple disease states and specialties. The company's Rapid Enterprise Platform connects intelligence, workflow, and care teams across health systems, providing AI-driven insights for neurovascular conditions (stroke, hemorrhage, aneurysm), cardiac and vascular diseases (aortic conditions, pulmonary embolism), and radiology workflows. RapidAI goes beyond simple anomaly detection to provide comprehensive clinical capabilities including triage, localization, quantification, characterization, visualization, and longitudinal tracking. The platform serves over 2,500 hospitals across 100+ countries, processing more than 20,000 daily scans. With 30 FDA-cleared modules and backed by extensive clinical validation including 750+ publications, 25+ clinical trials, and 11 New England Journal of Medicine publications, RapidAI has established itself as a clinically rigorous solution. The company's mobile app enables real-time collaboration and alerts for urgent cases, while its Navigator Pro and Rapid Insights tools provide imaging prioritization and custom performance analytics. RapidAI's approach emphasizes deep expertise in critical disease states rather than broad surface-level detection, equipping clinicians with actionable insights that drive meaningful patient outcomes while improving operational efficiency and financial viability for healthcare organizations.
Mission & Story
Mission
We challenge outdated thinking to deliver patient-centered innovation that changes outcomes.
Clinical Focus
Medical conditions and clinical areas addressed by iSchema View.
Who It Serves
Milestones & Awards
Recent Milestones
Lumina 3D named to TIME's Best Inventions list. Frost & Sullivan 2026 Radar ranked RapidAI as leader with 4.8/5.0 innovation score, ahead of 96% of industry. Platform expansion into cardiac, vascular, and radiology beyond neurovascular origins.
Awards & Recognition
TIME Best Inventions (Lumina 3D), Frost & Sullivan 2026 Intelligent Imaging Analysis Systems Radar - Leader position with 4.8/5.0 innovation score, Featured in Forbes on AI disruption in healthcare
Key Partnerships
Social & Media
Latest Updates
DUEL Study published in AJNR: Real-world data demonstrates superior performance for RapidAI in LVO detection
2w ago
The new radiology operating model: AI impact on how radiologists work
2w ago
AI Healthcare Platform: What Health Systems Need to Get Right
3w ago
The market has changed: Frost & Sullivan's 2026 Radar shows who's leading it
1mo ago
CT perfusion identifies more treatable stroke patients, without slowing care
1mo ago
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.